<DOC>
	<DOCNO>NCT00375323</DOCNO>
	<brief_summary>The purpose study compare effect recombinant factor VIIa ( NovoSeven ) restore coagulation activation patient hemophilia A antibody factor VIII normal subject ( control ) use vivo method .</brief_summary>
	<brief_title>Recombinant Factor VIIa ( NovoSeven ) Restoring Coagulation Activation</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Adult patient hemophilia A current antibody factor VIII Lifethreatening hemorrhage Severe liver failure Any severe comorbidity ( include diabetes mellitus , renal failure , cancer , septicemia , disseminate intravascular coagulation , crush injury ) Exposure haemostatic drug previous 7 day Hypersensitivity hamster , mouse bovine protein Known suspected allergy NovoSevenïƒ’ component</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>factor VIII inhibitor</keyword>
</DOC>